BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 28705667)

  • 1. Clinical characteristics of bacteraemia caused by Burkholderia cepacia complex species and antimicrobial susceptibility of the isolates in a medical centre in Taiwan.
    Chien YC; Liao CH; Sheng WH; Chien JY; Huang YT; Yu CJ; Hsueh PR
    Int J Antimicrob Agents; 2018 Mar; 51(3):357-364. PubMed ID: 28705667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of bacteraemia caused by Lactobacillus spp. and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2000-2014.
    Lee MR; Tsai CJ; Liang SK; Lin CK; Huang YT; Hsueh PR
    Int J Antimicrob Agents; 2015 Oct; 46(4):439-45. PubMed ID: 26298673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of different molecular and phenotypic methods for identification of environmental Burkholderia cepacia complex.
    Furlan JPR; Pitondo-Silva A; Braz VS; Gallo IFL; Stehling EG
    World J Microbiol Biotechnol; 2019 Feb; 35(3):39. PubMed ID: 30739255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of MALDI-ToF MS for species identification of Burkholderia cepacia complex clinical isolates.
    Fehlberg LC; Andrade LH; Assis DM; Pereira RH; Gales AC; Marques EA
    Diagn Microbiol Infect Dis; 2013 Oct; 77(2):126-8. PubMed ID: 23891221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients.
    Kenna DTD; Lilley D; Coward A; Martin K; Perry C; Pike R; Hill R; Turton JF
    J Med Microbiol; 2017 Apr; 66(4):490-501. PubMed ID: 28463663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix-assisted laser desorption/ionization time-of-flight MS for the accurate identification of
    Wong KSK; Dhaliwal S; Bilawka J; Srigley JA; Champagne S; Romney MG; Tilley P; Sadarangani M; Zlosnik JEA; Chilvers MA
    J Med Microbiol; 2020 Aug; 69(8):1105-1113. PubMed ID: 32597748
    [No Abstract]   [Full Text] [Related]  

  • 7. Polyphasic characterisation of Burkholderia cepaciacomplex species isolated from children with cystic fibrosis.
    Vicenzi FJ; Pillonetto M; Souza HA; Palmeiro JK; Riedi CA; Rosario-Filho NA; Dalla-Costa LM
    Mem Inst Oswaldo Cruz; 2016 Jan; 111(1):37-42. PubMed ID: 26814642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination antimicrobial susceptibility testing of Burkholderia cepacia complex: significance of species.
    Abbott FK; Milne KE; Stead DA; Gould IM
    Int J Antimicrob Agents; 2016 Nov; 48(5):521-527. PubMed ID: 27665523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accurate identification and epidemiological characterization of Burkholderia cepacia complex: an update.
    Devanga Ragupathi NK; Veeraraghavan B
    Ann Clin Microbiol Antimicrob; 2019 Feb; 18(1):7. PubMed ID: 30717798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burkholderia pseudomultivorans sp. nov., a novel Burkholderia cepacia complex species from human respiratory samples and the rhizosphere.
    Peeters C; Zlosnik JE; Spilker T; Hird TJ; LiPuma JJ; Vandamme P
    Syst Appl Microbiol; 2013 Oct; 36(7):483-9. PubMed ID: 23867250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Burkholderia cepacia complex species in cystic fibrosis patients in Argentina during the period 2011-2015.
    Cipolla L; Rocca F; Martinez C; Aguerre L; Barrios R; Prieto M
    Enferm Infecc Microbiol Clin (Engl Ed); 2018; 36(7):431-434. PubMed ID: 29055510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III.
    Mahenthiralingam E; Bischof J; Byrne SK; Radomski C; Davies JE; Av-Gay Y; Vandamme P
    J Clin Microbiol; 2000 Sep; 38(9):3165-73. PubMed ID: 10970351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PCR-based identification and characterization of Burkholderia cepacia complex bacteria from clinical and environmental sources.
    Seo ST; Tsuchiya K
    Lett Appl Microbiol; 2004; 39(5):413-9. PubMed ID: 15482431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endemic burkholderia cepacia bacteraemia: clinical features and antimicrobial susceptibilities of isolates.
    Yu WL; Wang DY; Lin CW; Tsou MF
    Scand J Infect Dis; 1999; 31(3):293-8. PubMed ID: 10482060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of patients with bacteraemia caused by Mycobacterium avium complex species and antimicrobial susceptibility of the isolates at a medical centre in Taiwan, 2008-2014.
    Lee MR; Chien JY; Huang YT; Liao CH; Shu CC; Yu CJ; Hsueh PR
    Int J Antimicrob Agents; 2017 Jul; 50(1):35-40. PubMed ID: 28478210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multilocus sequence analysis, biofilm production, antibiotic susceptibility and synergy tests of Burkholderia species in patients with and without cystic fibrosis].
    Akışoğlu Ö; Engin D; Sarıçam S; Müştak HK; Şener B; Hasçelik G
    Mikrobiyol Bul; 2019 Jan; 53(1):22-36. PubMed ID: 30683036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreasing the Cut-off Score Value of MALDI-ToF MS Increase the Identities of Burkholderia cepacia Complex Species.
    Vianna EF; Pentagna LSDS; Menezes NIM; de Freitas FAD; Leite CDCF; Albano RM; Leão RS; Marques EA
    Curr Microbiol; 2021 Jun; 78(6):2259-2263. PubMed ID: 33944984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species distribution and antimicrobial susceptibility of Burkholderia cepacia complex isolates in clinical infections: Experience from a tertiary care hospital, Southern India.
    Kumaresan M; Manoharan M; Sugumar M; Sistla S
    Indian J Med Microbiol; 2024; 49():100613. PubMed ID: 38750965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an Italian Cystic Fibrosis Center.
    Manno G; Dalmastri C; Tabacchioni S; Vandamme P; Lorini R; Minicucci L; Romano L; Giannattasio A; Chiarini L; Bevivino A
    J Clin Microbiol; 2004 Apr; 42(4):1491-7. PubMed ID: 15070994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burkholderia cepacia complex epidemiology in persons with cystic fibrosis from Australia and New Zealand.
    Kidd TJ; Douglas JM; Bergh HA; Coulter C; Bell SC
    Res Microbiol; 2008 Apr; 159(3):194-9. PubMed ID: 18356026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.